There is a reported risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors. The condition may be linked to underlying systemic vascular health issues, and retinal occlusions can potentially serve as an indicator of broader health problems, including stroke risk and undiagnosed diseases like leukemia. The relationship between retinal occlusions and systemic health is being explored in various studies and reports, with some cases highlighting the importance of ocular involvement in diagnosing and managing related conditions.